
COVID-19: Diagnosis and Management-Part II
- Length: 223 pages
- Edition: 1
- Language: English
- Publisher: Bentham Science Publishers
- Publication Date: 2021-06-28
- ISBN-10: 168108807X
- ISBN-13: 9781681088075
- Sales Rank: #0 (See Top 100 Books)
source link The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings.
follow url This book is divided into two parts (I and II). Part I provides comprehensive information about 1) History of Coronaviruses, 2) Epidemiology of COVID-19, 3) Clinical presentation of this viral disease and 4) COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1) the prevention and treatment methodology, 2) mortality and long-term complications, 3) COVID-19 vaccines and future perspectives.
enter site Key Features:
- Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students.
- Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19.
- Six chapters in the first part which focus on clinical basics of COVID-19.
- Six chapters in the second part which cover broader topics for practical infection control.
- Multiple tables and figures which summarize and highlight important points.
- Presents a summary of the current standards for the evaluation and diagnosis of COVID-19.
- Features a detailed list of references, abbreviations, and symbols.
https://www.annarosamattei.com/?p=hqjl8h1 This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVDI-19 diagnosis and management as part of their clinical training or professional work.
here Welcome Table of Content Title BENTHAM SCIENCE PUBLISHERS LTD. End User License Agreement (for non-institutional, personal use) Usage Rules: Disclaimer: Limitation of Liability: General: FOREWORD PREFACE List of Contributors Prevention of COVID-19: Facts to Overcome the Myths Abstract INTRODUCTION MEASURES TO PREVENT THE SPREAD, ASSOCIATED MYTHS AND FACTS Personal Protective Equipment (PPE) Head Covers Face Shield Mask Classification of Masks Single-Use Masks Surgical Masks Respirator or FFP Masks Non-respirator or Dust Masks FFP (Filtering Face Piece) Classification Masks used for Prevention of COVID-19 Transmission N-95 Mask Triple-layered Medical Mask Goggles Gloves Shoe Covers Gowns or Coveralls ISO 16603 Class-3 Exposure Pressure SANITIZATION AND DISINFECTION Hand Hygiene For Public Prevention of COVID-19 Among Frontline Healthcare Workers Cleaning of Vegetables-Fruits Safe Handling of Currency and Paper Documents Cough or Respiratory Etiquettes Precautions to be Taken While Coughing/Sneezing or Any Physical Contact Spitting or Littering in Public Disinfection of Public Places Disposal and Disinfection of PPEs WATER TREATMENT AND WASTE MANAGEMENT Management of Water and Faecal Waste Safety of Water Supplies SOCIAL MEASURES Physical Distancing Quarantine and Isolation Home Quarantine Institutional Quarantine Infrastructural Facilities Staff Guidelines Utility Guidelines Lockdown and Travel Restrictions Zonal Classification of the Geography PROPHYLAXIS FOR COVID-19 Dietary Recommendations for the Prevention of COVID-19 General Measures Medicinal Plant Measures/Procedures Medical Prophylaxis for Healthcare Workers and Contacts of a Positive Patient REGULAR SCREENING PRECAUTIONS FOR TRAVEL CONCLUSION List of Abbreviations CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES Current Treatment Methods for Coronavirus Disease-19 Abstract INTRODUCTION OVERVIEW OF VARIOUS TREATMENT STRATEGIES FOR COVID-19 Hydroxychloroquine HCQ in Treatment of COVID-19 Probable Mechanism of HCQ in Treatment of COVID-19 Remdesivir Remdesivir in Treatment of COVID-19 Probable Mechanism of Action of Remdesivir in Treatment of COVID-19 Lopinavir/Ritonavir Lopinavir/Ritonavir in Treatment of COVID-19 Probable Mechanism of Action of Lopinavir/ritonavir in COVID-19 Favipiravir Favipiravir in Treatment of COVID-19 Probable Mechanism of Action of Favipiravir in Treatment of COVID-19 Azithromycin (AZ) AZ in COVID-19 Treatment Probable Mechanisms of AZ in COVID-19 Treatment Arbidol Arbidol in Treatment of COVID-19 Probable Mechanism of Action Ribavirin Ribavirin in COVID-19 Treatment Probable Mechanism of Action in COVID-19 Treatment Teicoplanin Teicoplanin in COVID-19 Treatment Probable Mechanism of Action Ivermectin Ivermectin in Treatment of COVID-19 Probable Mechanism of Action in COVID-19 Nitazoxanide Nitazoxanide in COVID-19 Treatment Corticosteroids Corticosteroids in the Treatment of COVID-19 Immuno Modulating Agents-Interferons (IFN’s) IFN’s in Treatment of COVID-19 Probable Mechanism of Action of IFN’s in COVID-19 Monoclonal Antibody Therapy 80R Immunoglobulin G1 (IgG1) CR3014 Monoclonal Antibody Therapy in COVID-19 Treatment Tocilizumab Sarilumab Limitations and Suggestions Regarding mAb’s Triple Therapy Miscellaneous Drugs Herbal Drugs for COVID-19 Glycyrrhizin Glycyrrhizin in COVID-19 Hesperetin Baicalin Scutellarin Plasma Therapy Plasma Therapy in the Treatment of COVID-19 Potential of Stem Cell Therapy in COVID-19 BCG Vaccine VARIOUS REGULATORY GUIDELINES GIVEN BY NIH (NATIONAL INSTITUTE OF HEALTH) FOR TREATMENT OF COVID-19 CONCLUSION LIST OF ABBREVIATIONS AUTHORS CONTRIBUTION CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES COVID-19 and Mortality Abstract INTRODUCTION REPRESENTING MORTALITY – MORTALITY RATE VS. CASE-FATALITY RATE FALLACIES IN ESTIMATING MORTALITY USING CASE-FATALITY RATE REPORTING COVID-19-RELATED DEATHS COMPARING CASE-FATALITY RATES OF COVID-19 WITH OTHER RELATED VIRAL DISEASES COMPARING COVID-19 CASE-FATALITY RATES AMONG VARIOUS NATIONS CAUSES OF DEATH IN COVID-19 PARAMETERS PREDICTING MORTALITY IN COVID-19 Clinical Parameters Age Gender Symptoms Complications Comorbid Illness Smoking Secondary Infections Laboratory Parameters CONCLUSION ABBREVIATIONS CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES Long Term Complications of COVID-19 Abstract INTRODUCTION Long Term Complications of COVID-19 Complications of COVID-19 in Various Diseases Diabetes Mellitus (DM) Hematological Complications Cardiovascular Diseases Central Nervous System Complications Viral Encephalitis Infectious Toxic Encephalopathy and Cerebrovascular Disease Chronic Kidney Disease (CKD) Asthma and Respiratory Disorders Rheumatoid Arthritis (RA) Conclusion ABBREVIATIONS CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES Vaccine Development Abstract COVID-19: VACCINE DEVELOPMENT COVID-19 Vaccine development: Modulating the Host Immune System TYPES OF VACCINES AND THEIR CHARACTERISTICS Live-attenuated Virus and Inactivated Whole Virus Vaccines Subunit Vaccines Vaccines Based on Virus-like Particles (VLPs) Viral Vector-based Vaccines DNA Vaccines Novel Approaches: Usage of Multidisciplinary Fields Serum Albumin Strategy Natural Product (Plant) Based Technology Nanotechnology and Material Science mRNA Based Approaches Animal models to test the immunogenic potential of candidate vaccine antigens Animal Models Currently in Practice Humanized Mice Models Novel Approach of Using Zebrafish (Their Advantages) Current Status of Vaccine Development Bench to Bedside: Obstacles and Outcomes Lessons from Previous Vaccine Development List of abbreviations CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES The Future of COVID-19 Treatment Abstract INTRODUCTION Drugs Affecting Viral Replication and Translation in COVID-19 Disease Drugs Interfering with Inflammation and Overcoming Cytokine Storm in COVID-19 Disease Anticancer Drugs in the Treatment of COVID-19 Disease Antiparasitic, Antiprotozoal, and Antifungal Drugs in the Treatment of COVID-19 Disease Drugs Affecting the Renin-Angiotensin-Aldosterone System in COVID-19 Miscellaneous DISCUSSION AND CONCLUSION Abbreviations CONSENT FOR PUBLICATION CONFLICT OF INTEREST ACKNOWLEDGEMENTS REFERENCES
follow 1. Disable the https://etxflooring.com/2025/04/bzl0huvxl AdBlock plugin. Otherwise, you may not get any links.
see url 2. Solve the CAPTCHA.
watch 3. Click download link.
Buy Soma Watson Brand 4. Lead to download server to download.